These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9192538)

  • 1. Sertraline treatment of transition-associated anxiety and agitation in children with autistic disorder.
    Steingard RJ; Zimnitzky B; DeMaso DR; Bauman ML; Bucci JP
    J Child Adolesc Psychopharmacol; 1997; 7(1):9-15. PubMed ID: 9192538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sertraline response in adults with mental retardation and autistic disorder.
    Hellings JA; Kelley LA; Gabrielli WF; Kilgore E; Shah P
    J Clin Psychiatry; 1996 Aug; 57(8):333-6. PubMed ID: 8778118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sertraline in adults with pervasive developmental disorders: a prospective open-label investigation.
    McDougle CJ; Brodkin ES; Naylor ST; Carlson DC; Cohen DJ; Price LH
    J Clin Psychopharmacol; 1998 Feb; 18(1):62-6. PubMed ID: 9472844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders.
    Posey DJ; Guenin KD; Kohn AE; Swiezy NB; McDougle CJ
    J Child Adolesc Psychopharmacol; 2001; 11(3):267-77. PubMed ID: 11642476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sertraline-induced behavioral activation during the treatment of an adolescent with major depression.
    Guilé JM
    J Child Adolesc Psychopharmacol; 1996; 6(4):281-5. PubMed ID: 9231321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sertraline in children and adolescents with social anxiety disorder: an open trial.
    Compton SN; Grant PJ; Chrisman AK; Gammon PJ; Brown VL; March JS
    J Am Acad Child Adolesc Psychiatry; 2001 May; 40(5):564-71. PubMed ID: 11349701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodologies and outcomes from the sertraline multicenter flexible-dose trials.
    Rapaport MH; Wolkow RM; Clary CM
    Psychopharmacol Bull; 1998; 34(2):183-9. PubMed ID: 9640998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sertraline in the treatment of mixed anxiety and depression disorder].
    Carrasco JL; Díaz-Marsá M; Sáiz J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(3):141-5. PubMed ID: 9381956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug concentration monitoring with tolerability and efficacy assessments during open-label, long-term sertraline treatment of children and adolescents.
    Alderman J; Wolkow R; Fogel IM
    J Child Adolesc Psychopharmacol; 2006; 16(1-2):117-29. PubMed ID: 16553533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sertraline on mood and immune status in patients with major depression and HIV illness: an open trial.
    Rabkin JG; Wagner G; Rabkin R
    J Clin Psychiatry; 1994 Oct; 55(10):433-9. PubMed ID: 7961520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of atypical antipsychotics in the treatment of autistic disorder.
    Stachnik JM; Nunn-Thompson C
    Ann Pharmacother; 2007 Apr; 41(4):626-34. PubMed ID: 17389666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone treatment of children with autistic disorder: effectiveness, tolerability, and pharmacokinetic implications.
    Gagliano A; Germanò E; Pustorino G; Impallomeni C; D'Arrigo C; Calamoneri F; Spina E
    J Child Adolesc Psychopharmacol; 2004; 14(1):39-47. PubMed ID: 15142390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities.
    Valicenti-McDermott MR; Demb H
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):549-60. PubMed ID: 17069544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of treatment response to sertraline in depressed multiple sclerosis patients using the Carroll scale.
    Scott TF; Nussbaum P; McConnell H; Brill P
    Neurol Res; 1995 Dec; 17(6):421-2. PubMed ID: 8622794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, single-blind, trial of sertraline and buspirone for treatment of elderly patients with generalized anxiety disorder.
    Mokhber N; Azarpazhooh MR; Khajehdaluee M; Velayati A; Hopwood M
    Psychiatry Clin Neurosci; 2010 Apr; 64(2):128-33. PubMed ID: 20132529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study.
    Marcus RN; Owen R; Manos G; Mankoski R; Kamen L; McQuade RD; Carson WH; Corey-Lisle PK; Aman MG
    J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):229-36. PubMed ID: 21663425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of atomoxetine in children with severe autistic disorders and symptoms of ADHD: an open-label study.
    Charnsil C
    J Atten Disord; 2011 Nov; 15(8):684-9. PubMed ID: 20686100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder.
    Rynn MA; Siqueland L; Rickels K
    Am J Psychiatry; 2001 Dec; 158(12):2008-14. PubMed ID: 11729017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.
    Owen R; Sikich L; Marcus RN; Corey-Lisle P; Manos G; McQuade RD; Carson WH; Findling RL
    Pediatrics; 2009 Dec; 124(6):1533-40. PubMed ID: 19948625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.